www.aipessymposium.eu       www.aipes-eeig.org       2016 2015

SAVING COSTS IN CANCER

PATIENT MANAGEMENT

THROUGH NUCLEAR MEDICINE

An AIPES symposium organised under the auspices

of the ITRE and ENVI Committees of the European Parliament

Wednesday 28 September 2016

The Solvay Library, Brussels

Opening by MEP Aldo Patriciello and Jean-Michel Vanderhofstadt, President AIPES

“Is Molecular Imaging the New Personalized Medicine? Is PET the Answer?”
Piotr Maniawski MSc, Director Clinical Science Advanced Molecular Imaging, Philips

“At the advent of Personalized Medicine: SPECT/CT in the 21st Century”
Carl von Gall MD, Manager Global Clinical Marketing, Molecular Imaging, Siemens Healthineers

“The Cost Effectiveness of PET/CT”
David W. Lee PhD, General Manager & Head of Market Access, GE Healthcare

• “Detailed Imaging Techniques enable Personalized Treatment, 
thereby preserving the Quality of Life of our patients”
Prof Fred Verzijlbergen, Head of NM Department,
Erasmus Hospital Rotterdam, The Netherlands


Panel discussion: Speakers with Prof Ignasi Carrió Director of the Department of Nuclear Medicine at Hospital Sant Pau in Barcelona and Editor in Chief of the European Journal of Nuclear Medicine and Molecular Imaging


Moderators

• Adam Smith D.Phil., Chief Scientific Officer, Nobel Media AB

• Antonis Kalemis PhD, Vice-President AIPES

Closing: Jean-Michel Vanderhofstadt, President AIPES


Venue: Solvay Library - Parc Léopold, rue Belliard 137, 1040 Brussels Belgium

Cancer treatment, however, frequently raises concerns with respect to its efficacy and cost. These concerns can be addressed by molecular medicine and its concepts of combining image-guided diagnosis and therapies (i.e.  theranostics) and  through the use of targeted radionuclide therapies, in particular.

This symposium, jointly organized by AIPES and the EU will provide a forum to an audience interested in state-of-the-art cancer diagnosis and treatments. The particular benefits of molecular medicine and the overall societal and healthcare impacts within the area of cancer management will be highlighted in real-case and clinical scenarios, thereby catering to the knowledge and background of a range of political, healthcare and medical experts.

In brief, a series of presentations on the adoption of integrated molecular-radiological imaging (PET/CT and SPECT/CT), on economic benefits of molecular imaging and therapy, as well as on a clinical evidence and further challenges of molecular medicine in cancer patient management will be followed by a roundtable discussion to open the floor to a vivid exchange of thoughts and opinions by the experts.

PRESS RELEASE

Click the image to download the press release following the 2016 Aipes Symposium.
Available in English and French

English version

Version Française

Watch the 2015 Aipes Symposium